Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Ye, Yin ^a   Yin, De Tao ^a,c   Chen, Li ^a   Zhou, Quansheng ^d   Shen, Rulong ^a   He, Gang ^a   Yan, Qingtao ^a   Tong, Zhenyu ^a   Issekutz, Andrew C ^g   Shapiro, Charles L ^a,b   Barsky, Sanford H ^a,b   Lin, Haifan ^e   Li, Jian Jian ^f   Gao, Jian Xin ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PIWIL2 LIKE 40 PROTEIN; PIWIL2 LIKE 50 PROTEIN; PIWIL2 LIKE 60 PROTEIN; PIWIL2 LIKE 80 PROTEIN; PROTEIN BCL 2; STAT3 PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA; PIWIL2 PROTEIN, HUMAN; PRIMER DNA; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; EUCHROMATIN; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIMARY TUMOR; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; UPREGULATION; UTERINE CERVIX CANCER; ANIMAL; C57BL MOUSE; CELL TRANSFORMATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEM CELL; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOPLASMS; NF-KAPPA B; PRECANCEROUS CONDITIONS; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 78149432945     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013406     Document Type: Article

References (63)

1. Gao JX (2008) Cancer stem cells: the lessons from precancerous stem cells. J Cell Mol Med 12: 67-96.
2. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, et al. (2006) Cancer Stem Cells-Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells. Cancer Res 66: 9339-9344.
3. Gao J-X, Zhou Q (2009) Epigenetic progenitors in tumor initiation and development. Drug Discovery Today: Disease Models 6: 5-12.
4. Gao J-X (2010) Development of Tumor Stem Cells: Implication in Field Cancerization. In: Dakubo G, ed. Field Cancerization: Basic Science and Clinical Applications. Hauppauge, NY: Novascience.
5. Chen L, Shen R, Ye Y, Pu XA, Liu X, et al. (2007) Precancerous Stem Cells Have the Potential for both Benign and Malignant Differentiation. PLoS ONE 2: e293.
6. Shen R, Ye Y, Chen L, Yan Q, Barsky SH, et al. (2008) Precancerous stem cells can serve as tumor vasculogenic progenitors. PLoS ONE 3: e1652.
7. Bussolati B, Grange C, Sapino A, Camussi G (2008) Endothelial Cell Differentiation of Human Breast Tumor Stem/Progenitor Cells. J Cell Mol Med.
8. Damonte P, Hodgson JG, Chen J, Young L, Cardiff R, et al. (2008) Mammary carcinoma behavior is programmed in the precancer stem cell. Breast Cancer Research 10: R50.
9. Hong D, Gupta R, Ancliff P, Atzberger A, Brown J, et al. (2008) Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 319: 336-339.
10. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
11. Zhu L, Gibson P, Currle DS, Tong Y, Richardson RJ, et al. (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457: 603-607.
12. Becker L, Huang Q, Mashimo H (2008) Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. Scientific World Journal 8: 1168-1176.
13. Sasaki T, Shiohama A, Minoshima S, Shimizu N (2003) Identification of eight members of the Argonaute family in the human genome small star, filled. Genomics 82: 323-330.
14. Jaronczyk K, Carmichael JB, Hobman TC (2005) Exploring the functions of RNA interference pathway proteins: some functions are more RISCy than others? Biochem J 387: 561-571.
15. Yin H, Lin H (2007) An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster. Nature 450: 304-308.
16. Sugimoto K, Kage H, Aki N, Sano A, Kitagawa H, et al. (2007) The induction of H3K9 methylation by PIWIL4 at the p16Ink4a locus. Biochemical and Biophysical Research Communications 359: 497-502.
17. Cox DN, Chao A, Baker J, Chang L, Qiao D, et al. (1998) A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell selfrenewal. Genes Dev 12: 3715-3727.
18. Kuramochi-Miyagawa S, Kimura T, Ijiri TW, Isobe T, Asada N, et al. (2004) Mili, a mammalian member of piwi family gene, is essential for spermatogenesis. Development 131: 839-849.
19. Lee JH, Engel W, Nayernia K (2006) Stem cell protein Piwil2 modulates expression of murine spermatogonial stem cell expressed genes. Mol Reprod Dev 73: 173-179.
20. Deng W, Lin H (2002) miwi, a murine homolog of piwi, encodes a cytoplasmic protein essential for spermatogenesis. Dev Cell 2: 819-830.
21. Lee JH, Schutte D, Wulf G, Fuzesi L, Radzun HJ, et al. (2006) Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 15: 201-211.
22. Kuramochi-Miyagawa S, Kimura T, Yomogida K, Kuroiwa A, Tadokoro Y, et al. (2001) Two mouse piwi-related genes: miwi and mili. Mech Dev 108: 121-133.
23. Carmell MA, Xuan Z, Zhang MQ, Hannon GJ (2002) The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis. Genes Dev 16: 2733-2742.
24. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, et al. (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441.
25. Dawe RK (2004) RNA interference on chromosomes. Nat Genet 36: 1141-1142.
26. Folco HD, Pidoux AL, Urano T, Allshire RC (2008) Heterochromatin and RNAi Are Required to Establish CENP-A Chromatin at Centromeres. Science 319: 94-97.
27. Tomari Y, Du T, Zamore PD (2007) Sorting of Drosophila Small Silencing RNAs. Cell 130: 299-308.
28. Preall JB, Sontheimer EJ (2005) RNAi: RISC Gets Loaded. Cell 123: 543-545.
29. Tahbaz N, Kolb FA, Zhang H, Jaronczyk K, Filipowicz W, et al. (2004) Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer. EMBO Rep 5: 189-194.
30. Rand TA, Ginalski K, Grishin NV, Wang X (2004) Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proceedings of the National Academy of Sciences of the United States of America 101: 14385-14389.
31. Buhler M, Verdel A, Moazed D (2006) Tethering RITS to a nascent transcript initiates RNAi- and heterochromatin-dependent gene silencing. Cell 125: 873-886.
32. Liu JSR, Gang H, Chen L, Yin Y, Hua K, Jarjoura D, Nakano T, Ramesh GK, Shapiro CL, Barsky SH, Gao JX (2010) Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol 3: 328-337.
33. He G, Chen L, Ye Y, Xiao Y, Hua K, et al. (2010) Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16INK4a. Am J Transl Res 2: 156-169.
34. Feng DQ, Peng C, Li CR, Zhou Y, Li M, et al. (2009) Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncology Reports 22: 1129-1134.
35. Lee JH, Jung C, Javadian-Elyaderani P, Schweyer S, Schãjtte D, et al. (2010) Pathways of Proliferation and Antiapoptosis Driven in Breast Cancer Stem Cells by Stem Cell Protein Piwil2. Cancer Research 70: 4569-4579.
36. Qiao D, Zeeman AM, Deng W, Looijenga LH, Lin H (2002) Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminomas. Oncogene 21: 3988-3999.
37. Li L, Yu C, Gao H, Li Y (2010) Argonaute proteins: potential biomarkers for human colon cancer. BMC Cancer 10: 38.
38. Aravin A, Gaidatzis D, Pfeffer S, Lagos-Quintana M, Landgraf P, et al. (2006) A novel class of small RNAs bind to MILI protein in mouse testes. Nature 442: 203-207.
39. Aravin AA, Sachidanandam R, Girard A, Fejes-Toth K, Hannon GJ (2007) Developmentally regulated piRNA clusters implicate MILI in transposon control. Science 316: 744-747.
40. Grivna ST, Beyret E, Wang Z, Lin H (2006) A novel class of small RNAs in mouse spermatogenic cells. Genes Dev 20: 1709-1714.
41. Grivna ST, Pyhtila B, Lin H (2006) MIWI associates with translational machinery and PIWI-interacting RNAs (piRNAs) in regulating spermatogenesis. Proc Natl Acad Sci U S A 103: 13415-13420.
42. Lau NC, Seto AG, Kim J, Kuramochi-Miyagawa S, Nakano T, et al. (2006) Characterization of the piRNA complex from rat testes. Science 313: 363-367.
43. Saito K, Nishida KM, Mori T, Kawamura Y, Miyoshi K, et al. (2006) Specific association of Piwi with rasiRNAs derived from retrotransposon and heterochromatic regions in the Drosophila genome. Genes Dev 20: 2214-2222.
44. Brennecke J, Aravin AA, Stark A, Dus M, Kellis M, et al. (2007) Discrete small RNA-generating loci as master regulators of transposon activity in Drosophila. Cell 128: 1089-1103.
45. Dreesen O, Brivanlou A (2007) Signaling Pathways in Cancer and Embryonic Stem Cells. Stem Cell Reviews and Reports 3: 7-17.
46. Grandage VL, Gale RE, Linch DC, Khwaja A (2005) PI3-kinase//Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways. Leukemia 19: 586-594.
47. Ryu B, Kim DS, DeLuca AM, Alani RM (2007) Comprehensive Expression Profiling of Tumor Cell Lines Identifies Molecular Signatures of Melanoma Progression. PLoS ONE 2: e594.
48. Melcher R, Steinlein C, Feichtinger W, Muller CR, Menzel T, et al. (2000) Spectral karyotyping of the human colon cancer cell lines SW480 and SW620. Cytogenet Cell Genet 88: 145-152.
49. He G, Chen L, Ye Y, Xiao Y, Hua K, et al. (2010) Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16. Am J Transl Res 2: 156-169.
50. Liu JSR, Gang H, Chen L, Yin Y, Hua K, Jarjoura D, Nakano T, Ramesh GK, Shapiro CL, Barsky SH, Gao JX (2010) Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker. Int J Clin Exp Pathol 3: 10.
51. Nikpour P, Forouzandeh-Moghaddam M, Ziaee SA, Dokun OY, Schulz WA, et al. (2009) Absence of PIWIL2 (HILI) expression in human bladder cancer cell lines and tissues. Cancer Epidemiol 33: 271-275.
52. Chiu C-C, Chen JY-F, Lin K-L, Huang C-J, Lee J-C, et al. P38 MAPK and NFkB pathways are involved in naphtho[1,2-b] furan-4,5-dione induced antiproliferation and apoptosis of human hepatoma cells. Corrected Proof, In Press.
53. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
54. Wang J, Jacob NK, Ladner KJ, Beg A, Perko JD, et al. (2009) RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair. EMBO Rep 10: 1272-1278.
55. Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F (2005) Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer 93: 1019-1023.
56. Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458: 719-724.
57. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799.
58. Mader RM (2009) Disease models in cancer. Drug Discovery Today: Disease Models 6: 1-3.
59. Werbowetski-Ogilvie TE, Bhatia M (2008) Pluripotent human stem cell lines: what we can learn about cancer initiation. Trends in Molecular Medicine 14: 323-332.
60. Kim D-H, Behlke MA, Rose SD, Chang M-S, Choi S, et al. (2005) Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotech 23: 222-226.
61. Gao JX, Zhang J, Awaraji C, Bhatia M, Jevnikar A, et al. (2000) Preferential proliferation and differentiation of double-positive thymocytes into CD8(+) single-positive thymocytes in a novel cell culture medium. Cell Immunol 202: 41-53.
62. Gao JX, Liu X, Wen J, Zhang H, Durbin J, et al. (2003) Differentiation of Monocytic Cell Clones into CD8alpha(+) Dendritic Cells (DC) Suggests that Monocytes Can Be Direct Precursors for Both CD8alpha(+) and CD8alpha(-) DC in the Mouse. J Immunol 170: 5927-5935.
63. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. JExpMed 176: 1693-1702.